Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$38.46 - $50.95 $169,185 - $224,129
4,399 New
4,399 $213,000
Q3 2023

Nov 13, 2023

SELL
$40.03 - $51.51 $671,743 - $864,389
-16,781 Reduced 54.45%
14,036 $585,000
Q2 2023

Aug 10, 2023

SELL
$40.45 - $48.0 $172,761 - $205,008
-4,271 Reduced 12.17%
30,817 $1.34 Million
Q1 2023

May 12, 2023

BUY
$34.96 - $43.94 $335,336 - $421,472
9,592 Added 37.62%
35,088 $1.54 Million
Q4 2022

Feb 09, 2023

SELL
$36.55 - $51.15 $102,888 - $143,987
-2,815 Reduced 9.94%
25,496 $932,000
Q3 2022

Nov 14, 2022

SELL
$47.75 - $66.88 $733,153 - $1.03 Million
-15,354 Reduced 35.16%
28,311 $1.37 Million
Q2 2022

Aug 04, 2022

BUY
$40.55 - $51.76 $379,750 - $484,732
9,365 Added 27.3%
43,665 $2.15 Million
Q1 2022

May 13, 2022

SELL
$36.56 - $50.98 $645,759 - $900,459
-17,663 Reduced 33.99%
34,300 $1.75 Million
Q4 2021

Feb 10, 2022

BUY
$37.1 - $57.45 $556,500 - $861,750
15,000 Added 40.58%
51,963 $2.46 Million
Q3 2021

Nov 12, 2021

BUY
$38.45 - $55.66 $1.42 Million - $2.06 Million
36,963 New
36,963 $1.46 Million
Q2 2021

Aug 10, 2021

SELL
$49.67 - $68.96 $977,356 - $1.36 Million
-19,677 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$60.06 - $89.52 $9,069 - $13,517
151 Added 0.77%
19,677 $1.24 Million
Q4 2020

Feb 10, 2021

SELL
$53.26 - $77.18 $843,159 - $1.22 Million
-15,831 Reduced 44.77%
19,526 $1.4 Million
Q3 2020

Nov 12, 2020

SELL
$57.51 - $75.36 $211,579 - $277,249
-3,679 Reduced 9.42%
35,357 $2.67 Million
Q2 2020

Aug 13, 2020

SELL
$32.91 - $59.82 $2.23 Million - $4.06 Million
-67,911 Reduced 63.5%
39,036 $2.34 Million
Q1 2020

May 14, 2020

BUY
$26.79 - $38.99 $1.43 Million - $2.09 Million
53,528 Added 100.2%
106,947 $3.74 Million
Q4 2019

Feb 10, 2020

BUY
$29.07 - $35.63 $1.55 Million - $1.9 Million
53,419 New
53,419 $1.55 Million

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $584M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.